Canlyniadau Chwilio - Melero, Ignacio

Molecular and cellular basis for immunomodulation with monoclonal antibodies gan Melero, Ignacio

Cael y testun llawn Cael y testun llawn

4-1BB (CD137) in anticancer chimeras gan Melero, Ignacio, Berraondo, Pedro

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Initial Afferent Lymphatic Vessels Controlling Outbound Leukocyte Traffic from Skin to Lymph Nodes gan Teijeira, Alvaro, Rouzaut, Ana, Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Immunotherapy of hepatocellular carcinoma gan Sangro, Bruno, Palmer, Daniel, Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

High-density lipoproteins delivering interleukin-15 gan Ochoa, Maria C., Melero, Ignacio, Berraondo, Pedro

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint gan Wischhusen, Jörg, Melero, Ignacio, Fridman, Wolf Herman

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain gan Aznar, M Ángela, Melero, Ignacio, Quetglas, José I

Cael y testun llawn Cael y testun llawn Cael y testun llawn

T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy gan Melero, Ignacio, Rouzaut, Ana, Motz, GregT., Coukos, George

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy gan Ascierto, Maria Libera, Melero, Ignacio, Ascierto, Paolo Antonio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer gan Morales-Kastresana, Aizea, Labiano, Sara, Gütgemann, Ines, Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better? gan Perez-Gracia, Jose Luis, Sanmamed, Miguel F., Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis gan Etxeberria, Iñaki, Glez-Vaz, Javier, Teijeira, Álvaro, Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Advances in immunotherapy for hepatocellular carcinoma gan Sangro, Bruno, Sarobe, Pablo, Hervás-Stubbs, Sandra, Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Intratumoural administration and tumour tissue targeting of cancer immunotherapies gan Melero, Ignacio, Castanon, Eduardo, Alvarez, Maite, Champiat, Stephane, Marabelle, Aurelien

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes gan Yanguas, Alba, Garasa, Saray, Teijeira, Álvaro, Aubá, Cristina, Melero, Ignacio, Rouzaut, Ana

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Immunodivergence in Metastatic Colorectal Cancer gan de Andrea, Carlos E., Schalper, Kurt A., Sanmamed, Miguel F., Melero, Ignacio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

SimB16: Modeling Induced Immune System Response against B16-Melanoma gan Pappalardo, Francesco, Forero, Ivan Martinez, Pennisi, Marzio, Palazon, Asis, Melero, Ignacio, Motta, Santo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for Combination gan Melero, Ignacio, Martinez-Forero, Ivan, Dubrot, Juan, Suarez, Natalia, Palazón, Asis, Chen, Lieping

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Radiation effects on antitumor immune responses: current perspectives and challenges gan Walle, Thomas, Martinez Monge, Rafael, Cerwenka, Adelheid, Ajona, Daniel, Melero, Ignacio, Lecanda, Fernando

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Agonist antibodies to TNFR molecules that costimulate T and NK cells gan Melero, Ignacio, Hirschhorn-Cymerman, Daniel, Morales-Kastresana, Aizea, Sanmamed, Miguel F., Wolchok, Jedd D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn